A newly filed Form 4 with the Securities and Exchange Commission shows that Bankers Life & Casualty Co., acting in its capacity as a 10%+ owner, purchased a substantial block of shares in Privacore VPC Asset Backed Credit Fund on August 7, 2026. The filing shows no ticker symbol associated with the fund, consistent with … Read more
Aptiv PLC (APTV) Chair and CEO Kevin P. Clark disclosed an open-market purchase of 51,190 shares on August 10, 2026, according to a Form 4 filing with the SEC. The shares were bought at $48.89 apiece, for a total outlay of $2,502,684.22. Following the transaction, Clark holds 651,016 shares directly, a stake that reflects a … Read more
Foresite Capital Management V, LLC, a 10%+ owner of Latigo Biotherapeutics, Inc. (LTGO), disclosed an open-market purchase of 140,000 shares on August 10, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The shares were bought at $18.00 apiece, for a total transaction value of $2,520,000.00. This was a straightforward open-market … Read more
A newly filed Form 4 shows James B. Tananbaum, an insider at Latigo Biotherapeutics, Inc. (LTGO), purchased 140,000 shares of the company on the open market on August 10, 2026. The transaction was executed at $18.00 per share, for a total outlay of $2,520,000.00 out of the insider’s own funds. Unlike option exercises or grants … Read more
A newly filed Form 4 shows MA Eagle II Holdings Fund, listed as an insider of MA Specialty Credit Income Fund (SCISX), made a sizable open-market purchase of the fund’s shares. The transaction, dated August 6, 2026, involved 404,694 shares acquired at $24.71 apiece, for a total outlay of $10,000,000.01. This was not a grant, … Read more
Sanofi has disclosed a substantial open-market purchase of shares in Attovia Therapeutics, Inc. (ATTO), according to a Form 4 filed with the SEC. The filing shows Sanofi bought 300,000 shares on August 6, 2026 at a price of $17.00 per share, a transaction valued at $5,100,000.00. Following the purchase, Sanofi’s stake in Attovia stands at … Read more
A newly filed Form 4 with the Securities and Exchange Commission shows Kenta Kon, President and Director of Toyota Motor Corp (NYSE: TM), purchased 85,000 shares of the automaker’s stock on August 5, 2026. The transaction was executed on the open market, meaning Kon used his own funds to acquire the shares rather than receiving … Read more
Frazier Life Sciences XI, L.P., an insider at Attovia Therapeutics, Inc. (ATTO), disclosed an open-market purchase of 588,235 shares on August 6, 2026, according to a Form 4 filed with the SEC. The shares were bought at $17.00 apiece, for a total outlay of $9,999,995.00 — a purchase sized almost exactly to the $10 million … Read more
A newly filed Form 4 with the SEC shows Paul M. Meister, an insider at Aptiv PLC (NYSE: APTV), purchased 105,631 shares of the auto-technology supplier on August 5, 2026. The trade was executed at $47.33 per share, for a total outlay of $4,999,958.88 — just shy of the $5 million mark. This was an … Read more
A Form 4 filed with the Securities and Exchange Commission shows Lim Jung Jae, CEO, Interim CFO, and a director of Reborn Coffee, Inc. (NASDAQ: REBN), reported an open-market purchase of company stock dated July 14, 2026. According to the filing, Lim acquired 131,387 shares at a stated price of $180,000.00 per share, putting the … Read more
Andrew C. Florance, the founder and chief executive officer of CoStar Group, Inc. (NASDAQ: CSGP), disclosed an open-market purchase of company stock in a Form 4 filing tied to a transaction dated August 4, 2026. Florance bought 83,300 shares at a price of $29.89 per share, a total outlay of $2,489,837.00 paid with his own … Read more
A newly filed Form 4 shows that Harrison Street Real Assets Fund LLC, identified as a 10%-plus owner of 2023 ETF Series Trust (NFRX), purchased 372,856 shares on August 4, 2026, in an open-market transaction. The insider paid $26.82 per share, bringing the total outlay to $9,999,997.92 — just shy of the $10 million mark. … Read more